Bovaclox DC

Name:

 Bovaclox DC

Category:

 Intramammaries

Region:

 United Kingdom

Bovaclox DC (Dry Cow) is an off-white, stable intramammary suspension prepared under sterile conditions. Each single dose 4.5 g syringe contains: Cloxacillin (as benzathine salt) 500 mg Ampicillin (as the trihydrate) 250 mg in a long acting base with 3% aluminium stearate. Ampicillin and cloxacillin are semi-synthetic penicillins derived from 6-aminopenicillanic acid.

Bovaclox DC (Dry Cow) is formulated for use in the dairy cow (including heifers) at the point of drying off, that is immediately after the last milking of the lactation in order to treat existing mastitis and to provide protection against further infections during the dry period.

Bovaclox DC is a useful aid in reducing the incidence of summer mastitis in dry cows at risk.

Bovaclox DC is active against both Gram-positive and Gram- negative organisms which are associated with mastitis and is effective against Streptococcus agalactiae and other Streptococcus species, penicillin resistant and sensitive staphylococci, Corynebacterium species, Escherichia coli and other susceptible Gram-negative bacteria.

Benzathine cloxacillin and ampicillin trihydrate in a long acting aluminium stearate base maintain effective antibacterial levels in the dry cow udder for approximately four weeks and are non-irritant to udder tissue.

Dry off therapy: After the final milking of a lactation, clean and disinfect the teats and introduce the contents of one tube into each quarter via the teat canal.

Do not use on cows which have a very short dry period. Not intended for use within 49 days of calving. Milk for human consumption may only be taken from 156 hours after calving.

Should a cow calve earlier than 49 days after the last treatment, milk for human consumption may only be taken from 49 days plus 156 hours after the last treatment.

Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 28 days from the last treatment.

When infusing heifers it is important that the syringe nozzle is not introduced into the teat. The recommended procedure is as follows:

The animal(s) should be properly restrained. The teats are cleaned and disinfected. The teat orifice is located and the nozzle of the syringe placed against it but NOT inserted. When the syringe plunger is depressed the antibiotic passes easily through the teat into the udder.

In cows suffering from hypocalcaemia, milk should be tested for freedom of antibiotics before being used for human consumption.

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion, or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.

1.Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.

2.Handle this product with great care to avoid exposure, taking all recommended precautions.

3.If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention.

4.Wash hands after use.

Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.

Do not store above 25C.
The syringe may only be used once.
Part used syringes must be discarded.
Keep out of reach of children.

POM-V

Cartons of 24 and 120 syringes, each syringe containing 500mg cloxacillin as the benzathine salt and 250mg ampicillin as the trihydrate.

Norbrook Laboratories Ltd

Vm 02000/4046

Bovaclox DC must not be used in the treatment of lactating cows. Should this occur milk should be discarded for 30 days, following which time milk should be tested until antibiotic can no longer be detected.